InsidersTradesSigma
Track the 넥스트바이오메디컬 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 넥스트바이오메디컬 has logged 1 insider filings. Market capitalisation: €281.8bn. The latest transaction was filed on 11 March 2026 (Other). Among the most active insiders: 넥스트바이오메디컬. Every trade is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
넥스트바이오메디컬 is a company listed on the XKRX market, specializing in the healthcare and pharmaceutical sector. It focuses on developing innovative solutions to enhance healthcare.